BeStock  
Stocks › Biotechnology › RLAY

Relay Therapeutics RLAY

US equityMarket cap rank #2302Biotechnology
$16.12 +$0.21 (+1.32%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $16.19 +0.46%
Open$15.59
Prev close$15.91
Day range$15.17 – $16.33
Volume3.98M
Market cap$3.56B
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts6
Average target$29.00+79.9% vs. price
  • Buy 100%
Low $26.00Now $16.12Avg $29.00High $31.00

Recent rating changes

The last 20 actions on file set price targets from $20.00 to $31.00, averaging $26.83.

DateFirmRatingTarget
9 Nov 2026 H.C. Wainwright BUY $29.00
6 Nov 2026 JonesTrading BUY $31.00
5 Nov 2026 CCORF BUY $29.00
5 Nov 2026 BofA Securities BUY –
5 Nov 2026 Barclays BUY $30.00
27 Oct 2026 Guggenheim BUY $26.00
26 Oct 2026 CCORF BUY $29.00
23 Oct 2026 BofA Securities BUY $25.00
12 Oct 2026 BofA Securities BUY $25.00
27 Sep 2026 JonesTrading BUY $20.00
22 Sep 2026 JonesTrading BUY $20.00
21 Aug 2026 H.C. Wainwright BUY $29.00
20 Aug 2026 H.C. Wainwright BUY $29.00
14 Aug 2026 J.P. Morgan BUY $31.00
10 Aug 2026 Citizens JMP BUY $26.00
7 Aug 2026 JonesTrading BUY $20.00
7 Aug 2026 BofA Securities BUY $25.00
7 Aug 2026 Barclays BUY $30.00
6 Aug 2026 TD Cowen BUY –
6 Aug 2026 CCORF BUY $29.00

Discussion

No comments yet — be the first to weigh in on RLAY.

Sign in to join the discussion.

Scroll to Top